The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial
Abruptly ending financial support for effective state programs will only create instability that leads to worsened physical and mental health outcomes for beneficiaries who rely on the programs servicesprecisely the increased costs and service utilization that CMS wants to be avoiding
Additionally, storing peptides in airtight containers is crucial to protect them from moisture and air exposure, which maintains their integrity for Australia clinical investigations
While GLP-1 and GIP primarily manage glucose and appetite, the glucagon receptor agonism adds a powerful new dimension
Five of the compounds had a biphasic plasma concentration profile suggestive of, e.g., subjection to an enterohepatic circulation (see section 7 Elimination)
10.1016/j.molmet.2022.101500 79 LiX